ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
9.90
-0.16 (-1.59%)
At close: Aug 7, 2026, 4:00 PM EDT
9.75
-0.15 (-1.52%)
After-hours: Aug 7, 2026, 7:34 PM EDT
ADMA Biologics Employees
As of December 31, 2025, ADMA Biologics had 647 total employees, including 640 full-time and 7 part-time employees. The number of employees decreased by 38 or -5.55% compared to the previous year.
Employees
647
Change (1Y)
-38
Growth (1Y)
-5.55%
Revenue / Employee
$791,770
Profits / Employee
$261,141
Market Cap
2.22B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 647 | -38 | -5.55% | 640 | 7 |
| Dec 31, 2024 | 685 | 61 | 9.78% | 677 | 8 |
| Dec 31, 2023 | 624 | 7 | 1.13% | 624 | 0 |
| Dec 31, 2022 | 617 | 90 | 17.08% | 617 | 0 |
| Dec 31, 2021 | 527 | 120 | 29.48% | 527 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Vericel | 398 |
| Nuvation Bio | 307 |
| UroGen Pharma | 298 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Stoke Therapeutics | 170 |
| Rapport Therapeutics | 84 |
ADMA News
- 4 days ago - Adma Biologics reports Q2 EPS 16c, consensus 16c - TheFly
- 4 days ago - Adma Biologics backs FY26 revenue view $530M-$560M, consensus $534.37M - TheFly
- 4 days ago - ADMA Biologics Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - ADMA Biologics Earnings release: Q2 2026 - Filings
- 4 days ago - ADMA Biologics Quarterly report: Q2 2026 - Filings
- 4 days ago - ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 9 days ago - ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. - GlobeNewsWire
- 10 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOGICS, INC. Lawsuit - ADMA - PRNewsWire